Evidence map›Paper›PMID 33182665›Full record

ArticleMolecules (Basel, Switzerland)2020

Ana Damjanović, Branka Kolundžija, Ivana Z Matić, Ana Krivokuća, Gordana Zdunić, Katarina Šavikin, Radmila Janković, Jelena Antić Stanković, Tatjana P Stanojković

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Determination of Selected Isoquinoline Alkaloids fromInternational journal of molecular sciences · 2023
    Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Ana DamjanovićDepartment for Experimental Oncology, Institute of Oncology and Radiology of Serbia, 11 000 Belgrade, Serbia.ORCID 0000-0002-0781-8433
Branka KolundžijaDepartment for Experimental Oncology, Institute of Oncology and Radiology of Serbia, 11 000 Belgrade, Serbia.
Ivana Z MatićDepartment for Experimental Oncology, Institute of Oncology and Radiology of Serbia, 11 000 Belgrade, Serbia.
Ana KrivokućaDepartment for Experimental Oncology, Institute of Oncology and Radiology of Serbia, 11 000 Belgrade, Serbia.
Gordana ZdunićDepartment for Pharmaceutical Investigations and Development, Institute for Medicinal Plant Research, Dr. Josif Pančić, 11 070 Belgrade, Serbia.
Katarina ŠavikinDepartment for Pharmaceutical Investigations and Development, Institute for Medicinal Plant Research, Dr. Josif Pančić, 11 070 Belgrade, Serbia.
Radmila JankovićDepartment for Experimental Oncology, Institute of Oncology and Radiology of Serbia, 11 000 Belgrade, Serbia.
Jelena Antić StankovićDepartment for Microbiology and Immunology, Faculty of Pharmacy, University of Belgrade, 11 221 Belgrade, Serbia.
Tatjana P StanojkovićDepartment for Experimental Oncology, Institute of Oncology and Radiology of Serbia, 11 000 Belgrade, Serbia.
Oncology Institute of Vojvodina · RSInstitute for Plant Protection and Environment · RSUniversity of Belgrade · RS

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

A549 CellsAdenocarcinoma of LungAntineoplastic Combined Chemotherapy ProtocolsBerberinebeta CateninCell CycleCell MovementDNA-Binding ProteinsDoxorubicinDrug SynergismEndonucleasesGenetic Complementation TestHumansLung NeoplasmsMahoniaMatrix Metalloproteinase 2Berberinebeta CateninCTNNB1 protein, humanDNA-Binding ProteinsDoxorubicinEndonucleasesERCC1 protein, humanMatrix Metalloproteinase 2Matrix Metalloproteinase 9MMP2 protein, humanMMP9 protein, humanOccludinOCLN protein, humanPlant Extractscytotoxicitydoxorubicinhuman lung adenocarcinomaMahonia aquifoliummatrix metalloproteinases

Identifiers

PMID33182665
PMCPMC7697947
OpenAlexW3105590843

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.